Sandra Graham-Mason is an innovative and purposeful leader, with approximately 20 years of experience in the pharmaceutical industry. Known for creating patient centric solutions and driving innovative product and consumer launch strategies, Sandra delivers value for healthcare providers and patients alike.

An enthusiastic advocate for Diversity, Equity, and Inclusion (DEI), Sandra had led fully inclusive marketing outreach programs across her organization.
In recognition of Sandra’s leadership, she was honored as part of the 2024 MM&M Women of Distinction and in 2022 she received the Elite 100, Communicators Award in the Master Educator category for a DEI brochure highlighting the impact of skin cancer in people of color.

Sandra is committed to fostering inclusivity and improving patients’ treatment journey through impactful, strategic initiatives.